Cidel Asset Management Inc. increased its position in Relx Plc (NYSE:RELX) by 24.8% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,933 shares of the technology company’s stock after purchasing an additional 4,754 shares during the period. Cidel Asset Management Inc.’s holdings in Relx were worth $638,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Red Door Wealth Management LLC bought a new position in shares of Relx in the 2nd quarter worth $25,000. Lumature Wealth Partners LLC bought a new position in Relx during the 1st quarter valued at $61,000. Proequities Inc. lifted its stake in Relx by 14.0% during the 1st quarter. Proequities Inc. now owns 3,834 shares of the technology company’s stock valued at $96,000 after acquiring an additional 470 shares in the last quarter. Bessemer Group Inc. lifted its stake in Relx by 421.1% during the 2nd quarter. Bessemer Group Inc. now owns 3,627 shares of the technology company’s stock valued at $97,000 after acquiring an additional 2,931 shares in the last quarter. Finally, Toronto Dominion Bank lifted its stake in Relx by 38.0% during the 2nd quarter. Toronto Dominion Bank now owns 3,980 shares of the technology company’s stock valued at $106,000 after acquiring an additional 1,095 shares in the last quarter. Institutional investors own 5.97% of the company’s stock.
Several equities analysts have weighed in on RELX shares. Exane BNP Paribas upgraded Relx from a “neutral” rating to an “outperform” rating in a research note on Thursday, July 1st. BNP Paribas upgraded Relx from a “neutral” rating to an “outperform” rating in a research note on Thursday, July 1st. Barclays restated an “overweight” rating on shares of Relx in a research note on Friday, July 30th. Societe Generale reaffirmed a “buy” rating on shares of Relx in a research report on Monday, August 2nd. Finally, UBS Group reaffirmed a “neutral” rating on shares of Relx in a research report on Monday, June 28th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $34.00.
The company also recently disclosed a dividend, which was paid on Monday, September 13th. Investors of record on Friday, August 6th were issued a $0.3351 dividend. The ex-dividend date was Thursday, August 5th. This represents a yield of 2.28%. This is a positive change from Relx’s previous dividend of $0.17. Relx’s dividend payout ratio (DPR) is 38.24%.
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Story: How is a management fee different from a performance fee?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.